CVD REAL: Primary Prevention for SGLT-2 Inhibitors in Diabetes? - Medscape

Medscape

CVD REAL: Primary Prevention for SGLT-2 Inhibitors in Diabetes? Medscape SAN DIEGO — A new analysis of the observational CVD REAL study of patients with type 2 diabetes starting on sodium glucose cotransporter-2 (SGLT2) inhibitors, deciphering outcomes according to baseline cardiovascular disease (CVD) status of the ...